Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia
Clinical trial NCT02954471 · COMPLETED
Trial details
- NCT number
- NCT02954471
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-10-21
- Primary completion
- 2019-09-17
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.